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1. Introduction
Microcystins (MCs) are toxins produced by cyanobacteria from water environments that can
induce acute and chronic effects on humans and animals, after ingestion/contact with conta‐
minated water [1]. This group of cyclic heptapeptides comprises approximately 80 variants,
being microcystin-LR (MCLR) the most frequent and toxic variant [1]. MCs are mainly known
for their hepatotoxicity due to their inhibitory activity of serine/threonine phosphatases PP1
and PP2A [2]. This inhibition interferes with hepatocyte homeostasis and structure, leading to
the collapse of liver tissue organization, liver necrosis and hemorrhage (Figure 1), which can
culminate, in severe cases, in the death of the intoxicated individuals [3, 4].
It has been reported that microcystins cross cell membranes through the transmembrane solute
carriers transport family OAPT (Organic Anion Polypeptide Transporters), in particular the
OATP1B1, OATP1B2, OATP1B3 and OATP1A2 [7, 8]. They are responsible for the sodium-
independent uptake of large amphipathic endogenous and exogenous organic anions into cells
and across the blood-brain barrier [9, 10]. The knowledge on the mechanism(s) of OATP-
mediated transport is still scarce [9] however, the available information suggests that, in a
general way, OATPs act as organic anion exchangers [11], functioning in a rocker-switch type
of mechanism and translocating the substrate through a central positively charged pore [9].
Some OATPs are expressed ubiquitously, whereas others are expressed in a tissue-specific
way [10]. In fact, the organotropism of MC is due to the selective uptake of microcystins by
the OATPs that are primarily expressed in liver [8], such as those mentioned above. For this
reason, the study of the toxicological properties of microcystins has been conducted mainly
in liver cells in vivo and cultured hepatic cells in vitro. However, OATP expression in other
organs has also been reported, like the case of OATP1A2 in the kidneys [7, 8, 10, 12] and an
increasing number of studies have been showing that MCLR can indeed induce nephrotox‐
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icity [13, 14, 15]. In fact, although MCLR is mostly accumulated in the liver and excreted by
biliary route, a fraction of the toxin (9%) is filtrated in the kidneys and eliminated through
the urine [16], which makes the kidneys a potential target for MCLR toxicity. In figure 2 is
depicted the toxicokinetics of microcystins.
Figure 1. Representation of the effects of microcystins in cytoskeleton, namely the changes of the hepatocytes and
sinusoidal capillary structure, and intrahepatic bleeding, mediated by the inhibition of protein phosphatases PP1 and
PP2A (partially adapted from [5] and [6]). Legend: H – hepatocyte; SC – Sinusoidal capillary; MC – microcystins; OH –
hydroxyl group; P – phosphate group; PP1 – protein phosphatase 1; PP2 – protein phosphatase 2.
Established cell lines have been considered, for a long time, as unsuitable to study the toxic
effects of MCs. This was due to the observation that, comparing with primary cell lines, high
amounts of MCs were required to elicit toxicity in permanent cell lines [17, 18, 19]. A proposed
explanation was the fact that established cell lines lose their OATPs, which render them unable
to uptake the toxin [19, 20]. Despite this fact, an increasing number of studies have demon‐
strated that MCs clearly induce toxic effects on several mammalian cell lines, in particular in
the human hepatoma HepG2 cell line [21-24]. Indeed, it was already demonstrated that OATP
transport system is preserved in the HepG2 cells [25].
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Figure 2. Schematic representation of MCLR absorption, distribution, metabolization and excretion (ADME) processes.
Legend: MCLR – microcystin-LR; MCLR-GSH – microcystin-LR conjugated with glutathione; MCLR-CYS – microcystin-
LR conjugated with cysteine.
When we started our work on MCLR toxicity in mammalian cell lines we evaluated the effects
of Microcystis aeruginosa extracts containing MCLR in the cell viability of AML12 (Mus
musculus hepatocytes, ATCC-CRL 2254), HepG2 (human hepatoma, ATCC-CRL 10741) and
Vero-E6 (african green monkey Cercopithecus aethiops kidney epithelial cells, ATCC-CRL 1586)
cell lines. Surprisingly, we observed that the dose-response curve of cell viability decrease
induced by MCLR was quite similar in Vero-E6 and in liver-derived cell lines [26]. Since then,
we have been demonstrated that MCLR induces a multiplicity of effects on Vero cells within
a wide range of concentrations [26-30], according to a dose-effect relationship (Figure 3).
To our knowledge no previous study reported the expression of OATPs in Vero cell line,
neither if an alternative transport system is involved in the microcystin uptake by kidney cells.
The elucidation of this issue would be obviously an important contribution to the knowledge
of microcystins toxicokinetics in the kidney and, consequently, an important stimulus to the
investigation of microcystins toxicity in the kidneys.
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Figure 3. Dose-effect relationship of MCLR on Vero-E6 cell line.
The studies of MCs effects on cell lines often lead to contradictory results, given the fact that
distinct MC toxicity endpoints (mainly cytotoxicity and genotoxicity) have been studied in
diverse cell lines (and cell clones) under distinct exposure conditions (different doses-ranges,
time of exposure, MCs variants, etc). In our work with Vero-E6 cells we tested MCLR (both
pure toxin and from cyanobacterial extracts of M. aeruginosa) within a wide range of concen‐
trations (1 nM- 200 µM), using several endpoints and methodologies (cytotoxicity, morphol‐
ogy, genotoxicity, protein expression). In this chapter we will summarize our results and
discuss the utility of Vero-E6 cell line to evaluate the toxicological properties of MCLR.
2. Effects of MCLR in Vero-E6 cell line
2.1. Cell viability
In our studies with Vero-E6 cell line we have consistently observed that MCLR induces a
concentration-dependent decrease of cell viability [26, 27, 29, 30]. This was achieved using
distinct cell viability assays (MTT, Neutral Red and LDH release) and distinct toxin sources
(commercially available MCLR and M. aeruginosa extracts). We observed that the most
sensitive methods for cytotoxicity evaluation were MTT and Neutral Red assays [26, 27, 29]
and that the response of pure toxin and cyanobacterial extracts was quite similar with cytotoxic
thresholds within 22-50 µM of MCLR (Table 1). The MCLR-induced loss of Vero-E6 viability
was attributed to apoptosis and necrosis [29, 30] as widely described for various cell types in
vitro and in vivo [18, 31, 32].
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2.2. Cellular organelles
In Vero-E6 cell line, exposure to MCLR (within the micromolar concentrations range) affected
several cellular organelles in a concentration-dependent form (Table 1, Figure 3). In our articles,
we proposed that at lower MCLR concentrations, autophagy is triggered as a survival
mechanism of Vero cells, in an attempt to eliminate the toxin or/and the MCLR-induced cellular
damages [29, 30]. Also, we reported the vacuolization of the Golgi apparatus and cytoplasm,
effects also previously described in MCLR-exposed hepatocytes [17, 18]. The disorganization
of the microfilaments and microtubules, which is one of the most commonly described
cytotoxic effects of MCLR in hepatic cells [34-36], was also triggered by MCLR in Vero cells [29,
30]. The observation that MCLR induced the destructuring of the endoplasmic reticulum (ER)
suggested that this organelle is involved in MCLR toxicity in Vero cell line [29, 30]. The
involvement of the ER in MCLR-mediated toxicity was also previously reported in mouse
kidney and liver [37]. At higher concentrations, MCLR induced the disruption of the plasma
membrane, lysosomes and mitochondria of Vero cells [29, 30]. So far, studies that have used
other cell types proposed mitochondria as a major target of MCLR toxicity [38-42]. However,
studies with Vero cells show that mitochondria, although involved in MCLR-induced toxicity,
may not be the pivotal intracellular target of the toxin [29, 30].
2.3. Genotoxicity
Based on its tumour promoter activity MCLR is classified by the International Agency for
Research on Cancer as a potential human carcinogen (class 2B) [43]. In addition, some
epidemiologic studies have associated the increase of human hepatocarcinoma [44, 45] and
colorectal [46] cancers with the ingestion of water frequently contaminated with microcystins.
However it is still unclear if, besides a tumor promoter, MCLR can also act as a tumor initiator.
In fact, the potential genotoxicity of MCLR is still a matter of some controversy within the
scientific community, with several authors reporting apparently contradictory results.
The hypothesis of MCLR being a genotoxic compound was mainly supported by the evidence
that this toxin induces DNA damage in liver cells in vivo, in cultured hepatocytes and in some
non-liver cell lines (revised in [47]). This data was obtained by the Comet assay, which
measures DNA strand breaks that constitute primary DNA lesions with relevance for the
formation of gene and chromosome mutations [48]. Several mutagenicity studies excluded the
hypothesis of MCLR being a mutagen [49, 50], which was further supported by the fact that
MCLR do not form adducts with DNA that would represent a pre-mutagenic lesion [51]. On
the other hand, some authors reported that MCLR-induced DNA damage was a consequence
of early apoptosis due to oxidative stress and not a real genotoxic effect [52]. This hypothesis
was supported by the discovery that MCLR induces the formation of 8-oxo-dG, a marker of
oxidative DNA damage in liver cells [51].
Chromosome damage (aneugenesis/clastogenesis) has been suggested for microcystins by an
increase of the micronucleus (MN) frequency in mouse erythrocytes [49] and in the human
TK6 cell line [53]. However, no effect on the micronucleus frequency has been reported for
other cell types [50, 54-56] neither chromosome aberrations have been described so far [54, 57].
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Some authors have also proposed that MCLR might interfere with DNA repair processes,
namely the repair of gamma radiation and ultra-violet-induced DNA damage [52, 54, 57], thus
increasing the genotoxic potency of those agents and contributing to their carcinogenesis.
Toxin concentration that elicited effect at 24 h
(extension of effect) Methods References
Effects Pure MCLR Cyanobacteria extract w/ MCLR
Cytotoxicity
(cell viability decrease)
25 – 200 µM (52-82%) 22-175 µM (55-58%) MTT assay [27]
_ 30 µM - 150 µM (35-67%) MTT assay [29]
_ 30 µM - 150 µM (26-79%) Neutral Red assay [29]
50 -100 µM (48-66%) 50 -100 µM (80-82%) Neutral Red assay [30]
200 µM (55%) 88-175 µM (38-29%) LDH release [27]
Cellular organelles
damages and /or
changes
Autophagosome induction
_
5-12 µM
TEM
(Immuno)fluorescence
microscopy
Tunnel assay
[29, 30]
Endoplasmic reticulum 5-50 µM
Cytoskeleton damages 12-50 µM
Lysosome rupture
20-50 µM
Mitochondria damages
Apoptosis 20-50 µM (13-27%)
Necrosis 12-100 µM (10-25%)
Genotoxicity Within micromolar range 20 and 40 µM (3.4 and 4.1 fold) Micronucleus assay [26, 58]
ERK1/2 activation 5-5000 nM (2.8–4 fold) 5-5000 nM (1.7–3.7 fold) Western Blot
[28]
Cell proliferation 1– 10 nM (1.5-2.1 fold) - BrdU incorporation assay
Table 1. Effects induced by pure MCLR and toxic M. aeruginosa extracts in Vero-E6 cell line: effective toxin
concentrations, effect extension and methods used in their evaluation.
In our early studies with the Vero-E6 cell line we demonstrated that cyanobacterial extracts
from a MCLR-producer cyanobacterial strain increased the frequency of micronuclei at non-
cytotoxic concentrations [26]. Afterwards, we confirmed this observation using pure MCLR
[58, submitted for publication]. In this study, we found that MCLR induces the micronucleation
of Vero-E6 and human hepatoma HepG2 cell lines. In order to disclose the mechanism
underlying micronuclei formation we used the centromere labelling Fluorescent in situ
Hybridization technique in HepG2 exposed cells to MCLR (since there are no commercial
centomere probes for monkey cells) and we observed that MCLR induced both centromere-
positive and centromere-negative micronuclei [58]. Our data, together with those from other
works, suggests that MCLR genotoxicity occurs indirectly by both clastogenic and aneugenic
mechanisms: the first, possibly through oxidative stress; the second, perhaps through damages
on the mitotic spindle, induced by the inhibition of PP1/PP2A. Since clastogenesis and
aneugenesis have been associated with human cancer development [59] it can be hypothesized
that both underlie the carcinogenic activity of MCLR. Moreover, the confirmation of genotoxic
activity of MCLR in vivo is of major importance for regulatory purposes because a safe level
could not be applied to clastogens conversely to aneugens [59, 60]. This is fundamental for the
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prevention of the risk of exposure of human populations to water contaminated with toxic
cyanobacteria.
In figure 4 we summarize the proposed effects/mechanisms of MCLR genotoxicity, based on
the previous reports from other authors and our own contribution.
Figure 4. Representation of possible mechanisms of genotoxicity induced by MCLR. Legend: MCLR – microcystin-LR;
PP1 – protein phosphatase 1; PP2 – protein phosphatase 2; ROS – reactive oxygen species.
2.4. Cell proliferation
It is generally assumed that MCLR is a potent tumor promoter. This assumption is based on
rodent carcinogenicity studies which revealed that MCLR is able to induce cellular transfor‐
mation of rat liver [61] and mouse skin [62] of animals previously exposed to a genotoxic agent.
However, the mechanisms underlying MCLR-induced tumor promotion are still unknown. It
has been suggested that this activity is mediated by the inhibition of serine/threonine phos‐
phatase PP1 and PP2A, given their role on the regulation of cellular division and proliferation,
namely through the activation of Mitogen-Activated Protein Kinases (MAPK) [63]. MAPKs
are involved in signaling pathways that regulate many cellular processes through phosphor‐
ylation cascades, in particular the Ras-Raf-MEK1/2-ERK1/2 cascade, with a key role in cellular
proliferation and being regulated by several types of phosphatases including the serine/
threonine phosphatases PP1 and PP2A [64]. The Ras-Raf-MEK1/2-ERK1/2 cascade is activated
by growth factors and mitogenic agents (Figure 5). They bind to tyrosine kinase membrane
receptors (RTK), which activate the membrane G-protein GTPase, the recruitment and
activation of Raf protein and the subsequent phosphorylation cascade of ERK1/2 pathway [65].
The activated (phosphorylated) forms of ERK1/2 are translocated to the cell nucleus, inducing
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justify the distinct sensitivities observed among several authors. Further studies would also
be required to conclude if the effects of MCLR on kidney cells could be species-dependent.
Overall, the cytotoxic, morphological and ultrastructural effects of MCLR on Vero-E6 cell line
reported by us are quite similar to those reported for other cell lines. However, we observed
these effects at lower concentrations, which might suggest an eventual higher sensitivity of
Vero-E6 cell line comparing to other kidney cell lines.
4. Is Vero-E6 cell line a suitable model to study toxicological properties of
microcystins?
The assessment of kidney injury/dysfunction in vivo presents some complexity given the fact
that the kidney is constituted by over 20 different cell types exhibiting distinct morphologies
and functions and, consequently, diverse responses to toxic compounds [75, 76]. For this
reason, in vitro models are useful tools to assess specific nephrotoxic effects on specific cell
types [75]. Renal epithelial cell lines, in particular, present some advantages: there are several
well characterized commercially available clones, they are easy to grow and manipulate and
some of them retain basic functions of their original ancestors from kidney in vivo [76]. Specific
biochemical, morphological and functional markers such as transepithelial resistance and
transport, might therefore be used as endpoints of nephrotoxicity in vitro [75-77].
Vero-E6 monkey kidney cell line has been widely used on toxicology, virology and pharma‐
cology research, as well as, on the production of vaccines and diagnostic reagents [78]. In
particular, these cells have been used as model for assays to evaluate the toxicity of compounds
of different nature, either chemical or microbial toxins. The chemical substances tested include
carbamazepine [79]; triclosan [80]; lead nitrate [81]; pentachlorophenol and rotenone [82],
where the Vero cell line revealed to be one of the most sensitive model used in these studies.
These cells have also been validated as a cellular model for other microbial toxins such as
diphtheria toxin, a polypeptide with 535 a.a. [83] and Shiga-like toxins, a protein of enterohe‐
morrhagic Escherichia coli [84]. The sensitivity of Vero cell line to another cyanobacterial toxin,
cylindrospermopsin, was also reported although, such as MCs, the mechanism of toxin uptake
by this cell line remains to clarify [85, 86].
In our studies on the effects of MCLR on Vero-E6 cell line we did not evaluate any specific
nephrotoxicity marker. Instead, we evaluated the basal toxicity of MCLR, that is, the effects
that might be common to all cell types [87].
Using diverse methodologies including standard methods to evaluate cytotoxicity (Neutral
Red, MTT and Lactate Dehydrogenase release) and genotoxicity (Micronucleus and Comet
assay) we observed that MCLR induces a multiplicity of effects on Vero-E6 cells at distinct
levels: cellular morphology/ultrastructure, cell viability/death, MAPK expression and geno‐
toxicity (as referred in section 2). The type and extension of these effects were highly dependent
of toxin concentration and, generally, a dose-response relation could be established: for a dose
range of 1-10 nM, MCLR stimulates cell proliferation through the activation of the mitogen
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activated protein kinase ERK1/2 signalling pathway; however, within the µM range, MCLR
triggers a variety of effects in almost all cell compartments, from genotoxicity (induction of
micronuclei) and autophagy to apoptotic and necrotic cell death. Therefore, MCLR induces a
dual effect on the Vero-E6 cell line: at low doses it stimulates the cell growth but at high doses
it induces a decrease in viability and cell death (Figure 6).
Figure 6. Hormetic dose-response curves of MCLR on the growth of Vero-E6 cells.
This duality of low-dose growth stimulation vs high-dose growth inhibition was commented
by Li et al [88] as a characteristic hormetic dose-response phenomenon, such as they observed
for the low-dose PP2A stimulation vs high-dose PP2A inhibition by MCLR. However,
additional experiments would be required to support the hypothesis of MCLR exhibiting a
hormesis dose-response relation.
Another aspect we would like to underline is that we can attribute with high certainty the
observed responses of Vero-E6 cell line to MCLR exposure. The results obtained with toxic
cyanobacterial extracts are often questioned due to the uncertainty of cyanobacteria extracts
composition and the putative interference between cyanotoxins and other cyanobacterial
bioactive compounds [89]. In our studies, we tested two sources of MCLR: cyanobacterial
extracts from MCLR-producers (strains of Microcystis aeruginosa LMECYA 7, LMECYA 110
and LMECYA 113) [90] and commercially available pure MCLR. We have included in our
experiments two types of controls: culture medium when using pure toxin and a cyanobacterial
extract from a non toxic Microcystis aeruginosa strain (LMECYA 127) when using the toxic
cyanobacterial extract. All the strains of M. aeruginosa were phylogenetically close related [91]
and the ability (or inability) to produce MCLR was previously tested by several analytical
methodologies [92]. According to our results on cytotoxicity, genotoxicity and ERK1/2 (MAPK)
activation, all toxin solutions induced statistically significant responses in relation to respective
controls. Besides, the type and extension of effects were quite similar irrespectively of the toxin
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source (Table 1) and the results were repeatable after performing independent experiments.
In this sense we conclude that the observed effects were induced specifically by MCLR.
Usually it is assumed that high amounts of MCLR are required to elicit any effect on cell lines
comparing to primary cells [19]. This is true, but it also depends on the effects that are being
evaluated. In fact, cytotoxic MCLR concentrations for Vero cells were found within the range
of micromolar (µg/mL). However, the lowest concentration that elicited an effect (cell prolif‐
eration) on Vero-E6 cell line was 1 nM (µg/L) [28]. Many of the effects induced by MCLR in
Vero-E6 cell line were quite similar to those induced in the human hepatoma cell line (HepG2)
at similar dose-ranges. This applies to our data on MCLR genotoxicity on distinct cell models
[58] as well as on reported data from other authors [22, 47]. In fact, HepG2 cell line has been
considered a suitable model to evaluate the effects of MCLR on liver-derived cells, which
similarly might be applicable to Vero-E6 cell line regarding kidney-derived cells.
Considering all these aspects, we propose that Vero-E6 cell line is an appropriate in vitro cell
model to evaluate the basal toxicity of MCLR, although proper assessment of the specificity,
sensitivity, accuracy, among other parameters, will be required to validate this model.
Additionally, the elucidation of the MCLR uptake mechanism (OATPs or other transport
system), as well as the immunolocalization of MCLR within Vero cells, could be used to
confirm the access of this toxin to a kidney-derived cell line. Ultimately, further experiments
aiming at evaluate the effects of MCLR on specific kidney epithelial cells properties/nephro‐
toxic endpoints constitute a fundamental step in order to demonstrate the utility of Vero-E6
cell line as an in vitro model to investigate the nephrotoxic mechanisms of MCLR.
5. Concluding remarks
Despite the gaps in knowledge regarding the toxicological properties of microcystins, an
increasing number of recent publications emphasize the need to carefully evaluate their effects
on other organs besides the liver, particularly their carcinogenicity. The adverse effects of
MCLR in distinct organs is an important issue for risk assessment, because the guideline value
for MC in drinking water (1 nM) is still a provisional value, based on limited toxicological data
[93].
The exposure to low doses of MCLR corresponds to the most realistic kidney intoxication
scenario, considering that it is not the main target organ of this toxin. However, the role of
kidneys in toxin elimination might lead to the exposure of kidney cells to a low internal dose
that can be biologically effective in the induction of nephrotoxic effects. Besides, the chronic
adverse effects of microcystins on kidneys, specially the potential tumorigenic/carcinogenic
effects, may assume a particular importance in populations exposed to water persistently
contaminated with toxic cyanobacteria.
Although further studies will be required to recognize the epithelial monkey kidney-derived
Vero-E6 cell line as a nephrotoxicity model, we propose that Vero-E6 cell line constitutes a
valuable in vitro model to evaluate the basal toxicity of MCLR and to study the mechanisms
of MCLR toxicity.
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In figure 7 we summarize the effects induced by MCLR on Vero-E6 cell line.
Figure 7. Effects and mechanisms of toxicity of MCLR on Vero-E6 cell model. Legend: OATP (organic anion transport‐
ers polypeptide); PP1/PP2A (protein phosphatases PP1 and PP2A); P (phosphate group); ERK1/2 (extracellular-signal-
regulated kinase); TF (transcription factors); MT (microtubules); IF (intermediary filaments); MF (microfilaments); GSH
(reduced glutathione); ROS (reactive oxygen species); ER (endoplasmic reticulum); GC (golgi complex). ↓ Activation, ⊥
Inhibition.
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